Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis.
Achleitner M, Steenblock C, Dänhardt J, Jarzebska N, Kardashi R, Kanczkowski W, Straube R, Rodionov RN, Bornstein N, Tselmin S, Kaiser F, Bucher R, Barbir M, Wong ML, Voit-Bak K, Licinio J, Bornstein SR.
Achleitner M, et al. Among authors: kanczkowski w.
Mol Psychiatry. 2023 Jul;28(7):2872-2877. doi: 10.1038/s41380-023-02084-1. Epub 2023 May 2.
Mol Psychiatry. 2023.
PMID: 37131073
Free PMC article.